Log in to save to my catalogue

Capsazepine decreases corneal pain syndrome in severe dry eye disease

Capsazepine decreases corneal pain syndrome in severe dry eye disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b17ac4ae27b84d23a409b01aa36d7ff1

Capsazepine decreases corneal pain syndrome in severe dry eye disease

About this item

Full title

Capsazepine decreases corneal pain syndrome in severe dry eye disease

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2021-05, Vol.18 (1), p.111-111, Article 111

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Dry eye disease (DED) is a multifactorial disease of the ocular surface accompanied by neurosensory abnormalities. Here, we evaluated the effectiveness of transient receptor potential vanilloid-1 (TRPV1) blockade to alleviate ocular pain, neuroinflammation, and anxiety-like behavior associated with severe DED.
Chronic DED was induced by unilater...

Alternative Titles

Full title

Capsazepine decreases corneal pain syndrome in severe dry eye disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b17ac4ae27b84d23a409b01aa36d7ff1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b17ac4ae27b84d23a409b01aa36d7ff1

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-021-02162-7

How to access this item